Hunter syndrome: Difference between revisions

Revision as of 17:31, 18 February 2025

A rare genetic disorder affecting metabolism

Hunter syndrome, also known as mucopolysaccharidosis type II (MPS II), is a rare genetic disorder that primarily affects males. It is one of the lysosomal storage disorders and is caused by a deficiency of the enzyme iduronate-2-sulfatase. This enzyme deficiency leads to the accumulation of glycosaminoglycans (GAGs) in the body's cells, which can cause a variety of symptoms and complications.

Genetics

Hunter syndrome is an X-linked recessive disorder, meaning the defective gene is located on the X chromosome. Since males have only one X chromosome, a single defective gene is sufficient to cause the disorder. Females, having two X chromosomes, are typically carriers and usually do not exhibit symptoms, although some may have mild manifestations.

Pathophysiology

The enzyme iduronate-2-sulfatase is responsible for breaking down complex molecules known as glycosaminoglycans. In individuals with Hunter syndrome, the deficiency of this enzyme leads to the accumulation of GAGs, such as dermatan sulfate and heparan sulfate, in various tissues. This accumulation disrupts normal cellular function and leads to the symptoms associated with the disorder.

Symptoms

The symptoms of Hunter syndrome can vary widely among affected individuals and may include:

Developmental delay
Coarse facial features
Enlarged liver and spleen (hepatosplenomegaly)
Joint stiffness
Hearing loss
Heart valve abnormalities
Respiratory issues

Symptoms typically appear between the ages of 2 and 4 years and can progress over time. The severity of the disorder can range from mild to severe.

Diagnosis

Diagnosis of Hunter syndrome is based on clinical evaluation, family history, and laboratory tests. Enzyme assays can measure the activity of iduronate-2-sulfatase in blood or skin cells. Genetic testing can confirm the diagnosis by identifying mutations in the IDS gene.

Treatment

Currently, there is no cure for Hunter syndrome, but treatments are available to manage symptoms and improve quality of life. These include:

Enzyme replacement therapy (ERT) with idursulfase, which can help reduce GAG accumulation.
Supportive care, such as physical therapy, occupational therapy, and speech therapy.
Surgical interventions for complications like carpal tunnel syndrome or heart valve issues.

Prognosis

The prognosis for individuals with Hunter syndrome varies depending on the severity of the condition. Those with a milder form may live into adulthood, while those with a more severe form may have a reduced life expectancy due to complications such as respiratory failure or cardiac issues.

Related pages

@@ Line 1: / Line 1: @@
-'''Hunter syndrome''' is a very rare, inherited genetic disorder caused by a missing or malfunctioning enzyme. In Hunter syndrome, the body doesn't have enough of the enzyme iduronate 2-sulfatase. This enzyme's job is to break down certain complex molecules, and without enough of this enzyme, the molecules build up in harmful amounts.
+{{Short description|A rare genetic disorder affecting metabolism}}
+{{Medical resources}}
-==Symptoms==
+'''Hunter syndrome''', also known as '''mucopolysaccharidosis type II''' (MPS II), is a rare genetic disorder that primarily affects males. It is one of the [[lysosomal storage disorders]] and is caused by a deficiency of the enzyme iduronate-2-sulfatase. This enzyme deficiency leads to the accumulation of glycosaminoglycans (GAGs) in the body's cells, which can cause a variety of symptoms and complications.
-Symptoms of Hunter syndrome (also called [[Mucopolysaccharidosis II]] or MPS II) are often not visible at birth, but usually start to become noticeable after the first year of life. These symptoms can vary widely in severity.
+==Genetics==
+Hunter syndrome is an [[X-linked recessive]] disorder, meaning the defective gene is located on the X chromosome. Since males have only one X chromosome, a single defective gene is sufficient to cause the disorder. Females, having two X chromosomes, are typically carriers and usually do not exhibit symptoms, although some may have mild manifestations.
-===Physical Symptoms===
+==Pathophysiology==
-* Distinct facial features, including a broad nose and thick lips
+The enzyme iduronate-2-sulfatase is responsible for breaking down complex molecules known as glycosaminoglycans. In individuals with Hunter syndrome, the deficiency of this enzyme leads to the accumulation of GAGs, such as dermatan sulfate and heparan sulfate, in various tissues. This accumulation disrupts normal cellular function and leads to the symptoms associated with the disorder.
-* A large head
-* An enlarged abdomen
-* Diarrhea
-* White skin growths that resemble pebbles
-* Joint stiffness
-* Walking difficulties
-===Neurological Symptoms===
+==Symptoms==
+The symptoms of Hunter syndrome can vary widely among affected individuals and may include:
 * Developmental delay
-* Aggressive behavior
+* Coarse facial features
-* Hyperactivity
+* Enlarged liver and spleen ([[hepatosplenomegaly]])
-* Mental decline
+* Joint stiffness
 * Hearing loss
-* Heart problems
+* Heart valve abnormalities
+* Respiratory issues
-==Causes==
+Symptoms typically appear between the ages of 2 and 4 years and can progress over time. The severity of the disorder can range from mild to severe.
-Hunter syndrome is caused by a mutation in the [[IDS gene]]. This gene provides instructions for producing the enzyme iduronate 2-sulfatase, which is involved in breaking down large sugar molecules called glycosaminoglycans.
 ==Diagnosis==
-Diagnosis of Hunter syndrome is based on observing the physical symptoms, a detailed patient history, a clinical evaluation and a variety of specialized tests.
+Diagnosis of Hunter syndrome is based on clinical evaluation, family history, and laboratory tests. Enzyme assays can measure the activity of iduronate-2-sulfatase in blood or skin cells. Genetic testing can confirm the diagnosis by identifying mutations in the IDS gene.
 ==Treatment==
-There is no cure for Hunter syndrome. Treatment is focused on managing symptoms and improving quality of life. Enzyme replacement therapy (ERT) can help manage symptoms.
+Currently, there is no cure for Hunter syndrome, but treatments are available to manage symptoms and improve quality of life. These include:
+* [[Enzyme replacement therapy]] (ERT) with idursulfase, which can help reduce GAG accumulation.
+* Supportive care, such as physical therapy, occupational therapy, and speech therapy.
+* Surgical interventions for complications like carpal tunnel syndrome or heart valve issues.
-==See Also==
+==Prognosis==
+The prognosis for individuals with Hunter syndrome varies depending on the severity of the condition. Those with a milder form may live into adulthood, while those with a more severe form may have a reduced life expectancy due to complications such as respiratory failure or cardiac issues.
+==Related pages==
+* [[Lysosomal storage disorder]]
+* [[Mucopolysaccharidosis]]
 * [[Genetic disorder]]
-* [[Enzyme]]
+* [[Enzyme replacement therapy]]
-* [[Mucopolysaccharidosis]]
-* [[IDS gene]]
-==References==
-<references />
 [[Category:Genetic disorders]]
+[[Category:Lysosomal storage disorders]]
 [[Category:Rare diseases]]
-[[Category:Syndromes]]
-{{stub}}
-<gallery>
-File:Hunter_syndrome X-linked_recessive.svg|Diagram showing the X-linked recessive inheritance pattern of Hunter syndrome.
-File:Dermatan_sulfate.svg|Chemical structure of dermatan sulfate.
-</gallery>